The research, led by Karen L. Roper of the University of Kentucky College of Medicine’s Department of Family and Community Medicine, addresses a well-documented gap in the treatment landscape. Medications for opioid use disorder, commonly abbreviated as MOUD, are demonstrably effective at reducing illicit opioid use, overdose mortality, and relapse, yet the majority of people with opioid use disorder in the United States receive no pharmacological treatment at all. Buprenorphine, a partial opioid agonist that suppresses cravings and withdrawal without producing the full euphoric effect of full agonists, can be prescribed in office-based settings, making primary care an ideal delivery channel. Despite this, many primary care practitioners, or PCPs, cite a thicket of barriers: worry about staff and patient reactions, limited appointment time, reimbursement uncertainty, and a lack of confidence in managing a condition long stigmatized as outside the generalist’s lane.

What distinguishes this intervention is its deliberate grounding in the science of behavior change. Rather than producing generic continuing education content, the team scripted videos specifically tailored to the primary care environment, and especially to the realities of rural practice. The central video was delivered by a rural-setting PCP who described her extensive firsthand experience treating patients with buprenorphine, directly confronting the negative perceptions and practical barriers that clinicians most often raise. Supplementary videos were designed around two distinct motivational pathways: one emphasizing external motivation, such as clinic-level and societal benefits of expanding MOUD access, and the other emphasizing internal motivation, including the personal and professional rewards of treating addiction.

Methodologically, the study took the form of cross-sectional surveys administered through a continuing education platform alongside the videos. Participation was open to family and internal medicine professionals in Kentucky, including physicians, doctors of osteopathy, advanced practice registered nurses, and physician assistants. The survey instrument captured demographic information and career satisfaction, and used a Post/Retrospective-Pre format to assess change in the perceived importance of 19 distinct barriers to MOUD practice, along with confidence in four relevant practice areas. The retrospective-pre design asks respondents to rate their views before the intervention in hindsight after completing it, a technique that can capture shifts that participants might not have recognized in real time. The primary outcome was the learner’s stated intention to explore MOUD, while secondary measures rated the educational content for gains in clinical knowledge and skills and for usefulness of information.

The results, though drawn from a modest sample of 37 professional learners, were statistically meaningful. After viewing the videos, participants rated several prominent barriers as significantly less important, including concern about negative attitudes and perceptions across the practice, spanning staff, other practitioners, and patients; limited appointment time; and reimbursement of clinical visits. Fisher’s non-parametric tests yielded p-values at or below 0.05 for these reductions, suggesting the changes were unlikely to be due to chance alone. Perhaps most strikingly, the intervention appeared to touch something deeper than logistics: participants reported a strengthened sense that offering MOUD fits with one’s calling as a physician, an internal-motivation construct that the supplementary videos were explicitly designed to activate.

Behavioral intentions shifted as well. Viewers reported an increased likelihood to screen patients for opioid use disorder, a critical first step in the treatment cascade, since undiagnosed opioid use disorder cannot be treated. The study also uncovered an intriguing correlate: practitioners who scored higher on career satisfaction were more likely to consider board certification as an Addiction Medicine Specialist. This finding hints that clinician well-being and workforce development in addiction medicine may be intertwined, and that educational interventions could be tailored to leverage the professional fulfillment that many physicians derive from treating a condition they once avoided.

Open-ended feedback collected in the survey added qualitative texture to the quantitative findings, probing viewers’ reactions to specific aspects of the video content and its general impact. While the published abstract does not detail individual responses, the inclusion of these questions reflects a deliberate effort to understand not just whether the videos worked, but why, information that will be essential for scaling the approach beyond a single state. The educational content itself was rated positively for gains in clinical knowledge and skills and for the usefulness of the information presented, suggesting the format succeeded as continuing education even before its attitudinal effects are considered.

The significance of this work lies less in any single statistic than in its proof of concept. Expanding buprenorphine access has been a federal policy priority for years, with regulatory reforms eliminating the former X-waiver requirement and encouraging mainstreaming of addiction treatment into general medicine. Yet policy change alone has not moved the needle far enough, because the remaining barriers are psychological and cultural as much as regulatory. By demonstrating that brief, peer-delivered, behaviorally targeted video education can reduce the perceived salience of those barriers, the Kentucky team offers a low-cost, scalable template. A rural physician speaking to her peers in their own professional language may accomplish what guidelines and mandates have not.

The study’s limitations invite caution. With 37 participants drawn from a single state through a continuing education platform, the sample is small and self-selected; clinicians motivated enough to watch addiction-focused education may already be predisposed toward MOUD. The cross-sectional design cannot establish long-term durability of attitude change, and stated intention to explore MOUD does not guarantee that viewers will ultimately obtain the training and workflow supports needed to prescribe. Still, the authors conclude that education conceived for and specifically responsive to the primary care environment, and especially to the challenges of rural practice, can help overcome perceived barriers and promote consideration of MOUD service in primary care settings. In a crisis that claims tens of thousands of American lives annually, converting even a fraction of the nation’s primary care clinicians into buprenorphine prescribers could translate directly into saved lives, and this study suggests the conversion may begin with nothing more complicated than a colleague telling her story on camera.

Subject of Research: Impact of targeted educational videos on primary care practitioners' attitudes and intentions toward providing buprenorphine for opioid use disorder

Article Title: Changing minds on MOUD: impact of messages to motivate expanded access to buprenorphine in primary care settings

Article References: Changing minds on MOUD: impact of messages to motivate expanded access to buprenorphine in primary care settings. (n.d.). https://doi.org/10.1186/s13722-026-00719-6

Image Credits: AI Generated

DOI: 10.1186/s13722-026-00719-6

Keywords: buprenorphine, opioid use disorder, primary care, MOUD, rural health, continuing education, behavior change, addiction medicine, clinician attitudes, Kentucky, cross-sectional survey, career satisfaction